CS-206 in Patients With Sickle Cell Disease

NCT07000318 EARLY_PHASE1 NOT_YET_RECRUITING

The goal of this open label, single-arm clinical study is to learn about the safety and efficacy of CS-206 injection in treating sickle cell disease.

Details

Lead sponsor	Children's Hospital of Fudan University
Phase	EARLY_PHASE1
Status	NOT_YET_RECRUITING
Enrolment	5
Start date	Mon Jun 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Dec 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Sickle Cell Disease

Interventions

• CS-206

Countries

China